Welcome to LookChem.com Sign In|Join Free

CAS

  • or

10602-04-7

Post Buying Request

10602-04-7 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

10602-04-7 Usage

Description

4-Ethynylbenzyl alcohol, also known as 4-ETHYNYLBENZYL ALCOHOL 97, is an organic compound characterized by its unique structure that features an ethynyl group attached to a benzyl alcohol moiety. 4-ETHYNYLBENZYL ALCOHOL 97 is known for its versatile chemical properties and reactivity, making it a valuable building block in various synthetic applications.

Uses

Used in Chemical Synthesis:
4-Ethynylbenzyl alcohol is used as a key intermediate in the synthesis of complex organic molecules, such as platinum-acetylide dendrimers, rotaxanes, and arylacetylenes. Its unique structure allows for the formation of diverse molecular architectures with potential applications in various fields.
Used in Pharmaceutical Industry:
In the pharmaceutical industry, 4-Ethynylbenzyl alcohol is used as a precursor to synthesize arylalkyne-tagged sugars, which are essential for the photoinduced glycosylation of cysteine-containing peptides. This process plays a crucial role in the development of novel drug candidates and therapeutic agents.
Used in Material Science:
4-Ethynylbenzyl alcohol can also act as a precursor to synthesize fluorescent probes through a Cu(I)-catalyzed azide-alkyne cycloaddition (CuAAC) click reaction. These fluorescent probes are valuable tools in material science, as they can be used to study various biological processes and interactions at the molecular level.
Overall, 4-Ethynylbenzyl alcohol 97 is a versatile and valuable compound with a wide range of applications in chemical synthesis, pharmaceuticals, and material science, making it an essential component in the development of new technologies and products.

Check Digit Verification of cas no

The CAS Registry Mumber 10602-04-7 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 1,0,6,0 and 2 respectively; the second part has 2 digits, 0 and 4 respectively.
Calculate Digit Verification of CAS Registry Number 10602-04:
(7*1)+(6*0)+(5*6)+(4*0)+(3*2)+(2*0)+(1*4)=47
47 % 10 = 7
So 10602-04-7 is a valid CAS Registry Number.
InChI:InChI=1/C9H8O/c1-2-8-3-5-9(7-10)6-4-8/h1,3-6,10H,7H2

10602-04-7 Well-known Company Product Price

  • Brand
  • (Code)Product description
  • CAS number
  • Packaging
  • Price
  • Detail
  • Aldrich

  • (519235)  4-Ethynylbenzylalcohol  97%

  • 10602-04-7

  • 519235-5G

  • 3,235.05CNY

  • Detail

10602-04-7SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 18, 2017

Revision Date: Aug 18, 2017

1.Identification

1.1 GHS Product identifier

Product name (4-ethynylphenyl)methanol

1.2 Other means of identification

Product number -
Other names Benzenemethanol,4-ethynyl

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:10602-04-7 SDS

10602-04-7Relevant articles and documents

Synthesis of chiral helical poly(hydroxyl-containing phenylacetylene) membranes by in-situ depinanylsilylation and their enantioselective permeabilities

Teraguchi, Masahiro,Mottate, Kazuomi,Kim, Sun-Young,Aoki, Toshiki,Kaneko, Takashi,Hadano, Shingo,Masuda, Toshio

, p. 6367 - 6373 (2005)

Two new chiral helical poly(hydroxyl-containing phenylacetylene) membranes without the coexistence of any other chiral moieties were prepared in the following manner: (1) synthesis and homo-or copolymerization of two new chiral pinanylsiloxy-containing ph

Synthesis of siRNAs incorporated with cationic peptides R8G7 and R8A7 and the effect of the modifications on siRNA properties

Honda, Kenji,Kajino, Ryohei,Kakisawa, Yuri,Maeda, Yusuke,Matsubara, Miho,Ozaki, Koki,Ueno, Yoshihito

, p. 34815 - 34824 (2020)

Small interfering RNA (siRNA) can be used as an innovative next-generation drug. However, there are several challenges in the therapeutic application of siRNAs, including their low cell membrane permeability. In this study, we designed and synthesized siR

Chelation control through the coordination of Lewis acids to an acetylenic π-bond

Asao, Naoki,Asano, Toru,Ohishi, Takeshi,Yamamoto, Yoshinori

, p. 4817 - 4818 (2000)

-

Design, synthesis and antitumor evaluations of nucleoside base hydroxamic acid derivatives as DNMT and HDAC dual inhibitors

Sun, Qinsheng,Dai, Qiuzi,Zhang, Cunlong,Chen, Yan,Zhao, Lei,Yuan, Zigao,Jiang, Yuyang

, p. 2479 - 2483 (2021)

DNA methyltransferase (DNMT) and histone deacetylase (HDAC) are well recognized epigenetic targets for discovery of antitumor agents. In this study, we designed and synthesized a series of nucleoside base hydroxamic acid derivatives as DNMT and HDAC dual inhibitors. MTT assays and enzymatic inhibitory activity tests indicated that compound 204 exhibited potent DNMT1 and HDAC1/6 inhibitory potency simultaneously in enzymatic levels and at cellular levels, inducing hypomethylation of p16 and hyperacetylation of histones H3K9 and H4K8. Besides, 204 remarkably inhibited proliferation against cancer cells U937 by prompting G0/G1 cell cycle arrest. Molecular docking models explained the functional mechanism of 204 inhibiting DNMT1 and HDAC. Preliminary studies on metabolic profiles revealed that 204 showed desirable stability in liver microsomes. Our study suggested that 204 inhibiting DNMT and HDAC concurrently can be a potential lead compound for epigenetic cancer therapy.

Electrochemical Difunctionalization of Terminal Alkynes: Access to 1,4-Dicarbonyl Compounds

Hu, Jingcheng,Zeng, Li,Hu, Jiayu,Ma, Rui,Liu, Xue,Jiao, Ying,He, Haoyu,Chen, Siyu,Xu, Zhexi,Wang, Hongfei,Lei, Aiwen

supporting information, p. 289 - 292 (2022/01/04)

1,4-Dicarbonyl compounds are versatile scaffolds for the heterocycle synthesis, including the Paal-Knorr reaction. Herein, a feasible electrosynthesis method to access 1,4-dicarbonyl compounds has been developed from simple alkynes and 1,3-dicarbonyl compounds. When the undivided cell is combined with the constant current mode, aryl alkynes containing numerous medicinal motifs with 1,3-dicarbonyl esters or ketones react smoothly. External oxidant and catalyst-free conditions conform to the requirements of green synthesis.

Iron-Catalyzed Tertiary Alkylation of Terminal Alkynes with 1,3-Diesters via a Functionalized Alkyl Radical

Tian, Ming-Qing,Shen, Zhen-Yao,Zhao, Xuefei,Walsh, Patrick J.,Hu, Xu-Hong

supporting information, p. 9706 - 9711 (2021/03/19)

Direct oxidative C(sp)?H/C(sp3)?H cross-coupling offers an ideal and environmentally benign protocol for C(sp)?C(sp3) bond formations. As such, reactivity and site-selectivity with respect to C(sp3)?H bond cleavage have remained a persistent challenge. Herein is reported a simple method for iron-catalyzed/silver-mediated tertiary alkylation of terminal alkynes with readily available and versatile 1,3-dicarbonyl compounds. The reaction is suitable for an array of substrates and proceeds in a highly selective manner even employing alkanes containing other tertiary, benzylic, and C(sp3)?H bonds alpha to heteroatoms. Elaboration of the products enables the synthesis of a series of versatile building blocks. Control experiments implicate the in situ generation of a tertiary carbon-centered radical species.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 10602-04-7